IP Library Granted Patent US 7,674,903
Granted Patent B2
US 7,674,903 · App. 11/448,948 · Granted Mar 9, 2010

Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

Assignee: Nereus Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,674,903
App. No.
11/448,948
Granted
Mar 9, 2010
Kind
B2
Abstract

Compounds represented by the following structure (I) are disclosed: as are methods for making such compounds, wherein said methods comprise reacting a diacyldiketopiperazine with a first aldehyde to produce an intermediate compound; and reacting the intermediate compound with a second aldehyde to produce the class of compounds with the generic structure, where the first aldehyde and the second aldehydes are selected from the group consisting of an oxazolecarboxaldeyhyde, imidazolecarboxaldehyde, a benzaldehyde, imidazolecarboxaldehyde derivatives, and benzaldehyde derivatives, thereby forming the above compound wherein R 1 , R 1 ′, R 1 ″, R 2 , R 3 , R 4 , R 5 , and R 6 , X 1 and X 2 , Y, Z, Z 1 , Z 2 , Z 3 , and Z 4 may each be separately defined in a manner consistent with the accompanying description. Compositions and methods for treating cancer and fungal infection are also disclosed.

Claims (36)

1. A method for the synthetic preparation of a compound having the structure of Formula (I):

wherein

R 1 , and R 6 , are each separately selected from the group consisting of a hydrogen atom, a halogen atom, hydroxy, and cyano, or separately selected from the group consisting of saturated C 1 -C 24 alkyl, unsaturated C 2 -C 24 alkenyl, cycloalkyl, cycloalkenyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, azido, phenyl, carboxy, —CO—O—R 7 , alkylthio, monohalogenated alkyl, polyhalogenated alkyl, halogenated carbonyl, and carbonyl-CH 2 CO—R 7 , each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, acylamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO-alkyl, —SO-aryl, —SO-heteroaryl, —SO 2 -alkyl, —SO 2 -aryl, and —SO 2 -heteroaryl;

R 7 is selected from a hydrogen atom or a halogen atom, or selected from the group consisting of saturated C 1 -C 24 alkyl, unsaturated C 2 -C 24 alkenyl, cycloalkyl, cycloalkenyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, azido, and phenyl groups, each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, acylamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO-alkyl, —SO-aryl, —SO-heteroaryl, —SO 2 -alkyl, —SO 2 -aryl, and —SO 2 -heteroaryl;

R 4 is a tert-butyl group;

R 1 ′ and R 1 ″ are each independently selected from the group consisting of a hydrogen atom, a halogen atom, hydroxy, and cyano, or independently selected from the group consisting of saturated C 1 -C 24 alkyl, unsaturated C 2 -C 24 alkenyl, cycloalkyl, cycloalkenyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, azido, phenyl, carboxy, —CO—O—R 7 , alkylthio, monohalogenated alkyl, polyhalogenated alkyl, halogenated carbonyl, and carbonyl-CH 9 CO—R 7 , each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, acylamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO-alkyl, —SO-aryl, —SO-heteroaryl, —SO 2 -alkyl, —SO 2 -aryl, and SO 2 -heteroaryl;

R 1 , R 1 ′ and R 1 ″ are either covalently bound to one another or are not covalently bound to one another;

R 2 , R 3 , and R 5 are each separately selected from the group consisting of a hydrogen atom or a halogen atom, or separately selected from the group consisting of saturated C 1 -C 12 alkyl, unsaturated C 2 -C 12 alkenyl, acyl, cycloalkyl, alkoxy, cycloalkoxy, aryl, heteroaryl, amino, nitro, and sulfonyl groups, each optionally substituted with one or more of alkoxy, cycloalkyl, cycloalkenyl, acyl, acylamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyacylamino, cyano, halogen, hydroxy, carboxy, carboxyalkyl, aryl, aryloxy, heteroaryl, heteroaryloxy, hydroxyamino, alkoxyamino, nitro, —SO-alkyl, —SO-aryl, —SO-heteroaryl, —SO 2 -alkyl, —SO 2 -aryl, and —SO 2 -heteroaryl;

X 1 and X 2 are separately selected from the group consisting of an oxygen atom, a sulfur atom, or a nitrogen atom substituted with R 5 ;

Y is selected from the group consisting of (i) a nitrogen atom substituted with R 5 , (ii) an oxygen atom, (iii) a sulfur atom, (iv) an oxidized sulfur atom, and (v) a methylene group substituted with one or more R 5 ;

n is an integer equal to zero, one or two;

Z, for each separate n, if non-zero, and Z 1 , Z 2 , Z 3 and Z 4 are each separately selected from a carbon atom, a sulfur atom, a nitrogen atom or an oxygen atom; and

the dashed bonds may be either single or double bonds;

said method comprising:

reacting a diacyldiketopiperazine with an imidazolecarboxaldehyde to produce an intermediate; and

reacting said intermediate with a benzaldehyde to produce said compound.

2. The method according to claim 1 , wherein each of R 2 , R 3 , R 5 and R 6 is a hydrogen atom.

3. The method according to claim 1 , wherein each of X 1 and X 2 is an oxygen atom.

4. The method according to claim 1 , wherein R 1 comprises a substituted phenyl.

5. The method according to claim 4 , wherein said substituted phenyl group is methoxybenzene.

6. The method according to claim 1 , wherein n is equal to zero or one.

7. The method according to claim 1 , wherein n is equal to one.

8. The method according to claim 1 , wherein n is equal to one and Z, Z 1 , Z 2 , Z 3 and Z 4 are each a carbon atom.

9. The method of claim 1 , wherein Y is a nitrogen atom substituted with hydrogen.

10. The method of claim 1 , wherein said intermediate has the structure:

11. The method of claim 1 , wherein said imidazolecarboxaldehyde has the structure:

12. The method of claim 1 , wherein said reacting a diacyldiketopiperazine with an imidazolecarboxaldehyde to produce an intermediate is performed in the presence of a cesium salt.

13. The method of claim 1 , wherein said reacting a diacyldiketopiperazine with an imidazolecarboxaldehyde to produce an intermediate is performed in the presence of cesium carbonate.

14. The method of claim 1 , wherein said reacting a diacyldiketopiperazine with an imidazolecarboxaldehyde to produce an intermediate is performed in a deoxygenated atmosphere.

15. The method of claim 1 , wherein said reacting a diacyldiketopiperazine with an imidazolecarboxaldehyde to produce an intermediate is performed in the presence of dimethylformamide (DMF).

16. The method of claim 1 , wherein said reacting a diacyldiketopiperazine with an imidazolecarboxaldehyde to produce an intermediate is performed at room temperature.

17. The method of claim 1 , wherein reacting said intermediate with a benzaldehyde to produce said compound is performed in the presence of a cesium salt.

18. The method of claim 1 , wherein reacting said intermediate with a benzaldehyde to produce said compound is performed in the presence of cesium carbonate.

19. The method of claim 1 , wherein reacting said intermediate with a benzaldehyde to produce said compound is performed in a deoxygenated atmosphere.

20. The method of claim 1 , wherein reacting said intermediate with a benzaldehyde to produce said compound is performed in the presence of DMF.

21. The method of claim 1 , wherein reacting said intermediate with a benzaldehyde to produce said compound is performed at 80° C.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2016
From: HAYASHI, YOSHIO; PALLADINO, MICHAEL A., JR.; GRODBERG, JENNIFER
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 040348/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2014
From: DALIAN WANCHUN BIOTECHNOLOGY CO. LTD.
To: BEYONDSPRING PHARMACEUTICALS, INC.
Reel/Frame 033519/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2013
From: DALIAN WANCHUN BIOTECHNOLOGY CO. LTD.
To: BEYONDSPRING PHARMACEUTICALS, INC.
Reel/Frame 030723/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: NEREUS PHARMACEUTICALS, INC.
To: DALIAN WANCHUN BIOTECHNOLOGY CO. LTD.
Reel/Frame 030715/0457 →
SECURITY AGREEMENT Recorded May 21, 2009
From: NEREUS PHARMACEUTICALS, INC.
To: HBM BIOVENTURES (CAYMAN) LTD.; HBM BIOCAPITAL (EUR) L.P.; HBM BIOCAPITAL (USD) L.P.; PRIVATE LIFE BIOMED AG; ALSTERTOR PRIVATE LIFE GMBH & CO. KG; ADVENT HEALTHCARE AND LIFE SCIENCES III LIMITED PARTNERSHIP; ADVENT HEALTHCARE AND LIFE SCIENCES III-A LIMITED PARTNERSHIP; ADVENT PARTNERS HLS III LIMITED PARTNERSHIP; PACIFIC VENTURE GROUP II, L.P.; PVG ASSOCIATES II, L.P.; FORWARD VENTURES IV, L.P.; FORWARD VENTURES IV B, L.P.; GIMV N.V.; GIMV ADVIESBEHEER LIFE SCIENCES N.V.; LOTUS BIOSCIENCE INVESTMENT HOLDS LTD; NOVARTIS BIOVENTURE FUND / NOVARTIS INTERNATIONAL AIG; HENSLER, MARY; JACOBS, ROBERT; WS INVESTMENT COMPANY; GENAVENT PARTNERS LP; ASTELLAS VENTURE FUND I LP; ROCHE FINANCE LTD; ALTA CALIFORNIA PARTNERS II, L.P.; ALTA EMBARCADERO PARTNERS II, LLC; ALTA CALIFORNIA PARTNERS II, L.P. - NEW POOL
Reel/Frame 022719/0115 →
Continuity (5)
Division 1063253100 · Aug 1, 2003
Provisional Application 6045006300 · Feb 24, 2003
Provisional Application 6041112800 · Sep 16, 2002
Provisional Application 6040107400 · Aug 2, 2002
Related Publication 20060217553A1 · Sep 28, 2006